Patents by Inventor David Cram

David Cram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of isolating cells and uses thereof
    Publication number: 20050123914
    Abstract: The present invention relates to a non-invasive method of retrieving and identifying cells particularly fetal cells and trophoblastic cells. The invention includes methods for use of the cells for identifying chromosomal abnormalities and mutations particularly for prenatal diagnosis by performing genetic diagnosis for chromosomal and single gene disorders. The invention also includes methods of confirming cells of fetal origin.
    Type: Application
    Filed: September 6, 2002
    Publication date: June 9, 2005
    Inventors: Mandy Katz, David Cram
  • Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
    Patent number: 6211352
    Abstract: The present invention relates to the identification, cloning and sequencing of nucleic acid molecules encoding an isoform of the enzyme glutamic acid decarboxylase and further relates to the use of these molecules and/or peptides and polypeptides encoded thereby in diagnostic tests for Insulin Dependent Diabetes Mellitus and other diseases in which glutamic acid decarboxylase is an autoantigen and in the treatment of patients suffering from these diseases.
    Type: Grant
    Filed: July 29, 1998
    Date of Patent: April 3, 2001
    Assignee: Amrad Corporation Limited
    Inventors: Leonard Harrison, Margot Honeyman, David Cram, Henry De Aizpurua
  • Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides
    Patent number: 5837812
    Abstract: The present invention relates to the identification, cloning and sequencing of nucleic acid molecules encoding an isoform of the enzyme glutamic acid decarboxylase and further relates to the use of these molecules and/or peptides and polypeptides encoded thereby in diagnostic tests for Insulin Dependent Diabetes Mellitus and other diseases in which glutamic acid decarboxylase is an autoantigen and in the treatment of patients suffering from these diseases.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: November 17, 1998
    Assignee: Amrad Corporation Limited
    Inventors: Leonard Harrison, Margot Honeyman, David Cram, Henry De Aizpurua